Prion · 2013 · 26 citations · 28 references
Life SciencesMolecular BiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationNeurodegenerative DiseasesNeurodegenerative DisordersPrion Protein MisfoldingProtein AggregationAmyloid Beta PeptidesAmyloidogenic PeptidesBeta-sheet Rich StructuresCellular Prion Protein StructureNeurodegeneration PathogenesisPrion Protein OligomerizationPrion Substrate SpecificityProteinase-resistant Prion Protein
Alzheimer disease is associated with the accumulation of oligomeric amyloid β peptide (Aβ), accompanied by synaptic dysfunction and neuronal death. Polymeric form of prion protein (PrP), PrP(Sc), is implicated in transmissible spongiform encephalopathies (TSEs). Recently, it was shown that the monomeric cellular form of PrP (PrP(C)), located on the neuron surface, binds Aβ oligomers (and possibly other β-rich conformers) via the PrP(23-27) and PrP(90-110) segments, acting as Aβ receptor. On the other hand, PrP(Sc) polymers efficiently bind to Aβ monomers and accelerate their oligomerization. To identify specific PrP sequences that are essential for the interaction between PrP polymers and Aβ peptide, we have co-expressed Aβ and PrP (or its shortened derivatives), fused to different fluorophores, in the yeast cell. Our data show that the 90-110 and 28-89 regions of PrP control the binding of proteinase-resistant PrP polymers to the Aβ peptide, whereas the 23-27 segment of PrP is dispensable for this interaction. This indicates that the set of PrP fragments involved in the interaction with Aβ depends on PrP conformational state.
28
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Laurén, David A. Gimbel, Haakon B. Nygaard et al. · Nature · 2009 · 1.5K citations · Full text
Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor.
Ling Xie, Erik Helmerhorst, Kevin Taddei et al. · PubMed · 2002 · 504 citations · Full text